Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Survey reveals what men really know about birth control

NCT ID NCT07413484

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study surveyed 459 adult heterosexual men in France to evaluate their knowledge of both female and male contraception methods. The goal was to identify gaps in understanding that could be addressed through better sexual education. Researchers hope this information can help reduce the number of unwanted pregnancies and abortions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help tailor sexual education programs to better inform men about contraception, potentially reducing unwanted pregnancies.
What could go wrong
This is a survey study, not a treatment trial. It only measures knowledge and does not test any intervention, so it cannot directly change outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

459 people

The number who actually took part.

Started

Nov 2024

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

adult heterosexual men living in France (including overseas departments and territories), from all socio-professional categories, who agreed to take part in the study.

Ages

18 years and older

Sex

Male participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * male * of legal age * heterosexual * living in mainland France and the French overseas departments and territories * from all socio-professional categories * who agreed to take part in the study Exclusion Criteria: * females * minors * non-heterosexual * protected by law (guardianship, curatorship, safeguard of justice) * who refuse to take part in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contraception are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ufr Medecine Urca

    Reims, 51100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.